Real-time enrollment status for this acute liver failure clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 3:50 AM UTC
| NCT Number | NCT04862221 |
| Recruiting Status | Recruiting |
| Condition | Acute Liver Failure |
| Phase | PHASE2 |
| Target Enrollment | 163 participants |
| Active Locations | 24 sites in the US |
| Sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) |
| Last Updated on CT.gov | May 14, 2026 (May 14, 2026) |
As of July 17, 2026: Clinical trial NCT04862221 is currently recruiting participants. This phase2 study for acute liver failure is actively seeking new participants at 24 locations across the United States. The study is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04862221 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 24 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04862221 was last updated May 14, 2026 (May 14, 2026). HelloStudys verifies this status automatically.